

---

## K4 Package 2 · INDUSTRIALS_CAPITAL_GOODS · Checkpoint B implementation — 22 September 2026

Checkpoint A is frozen COMPLETE / PASS.

Implemented:
- `industrialsK4bScoringMethodology.ts`;
- `industrialsK4bScoringMethodology.test.ts`;
- `industrialsK4bIsolationRegression.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_2_INDUSTRIALS_CAPITAL_GOODS_CHECKPOINT_B.md`;
- canonical router extended for PROJECT_EPC / CAPITAL_EQUIPMENT_ELECTRICAL / DEFENCE_AEROSPACE;
- registry maps all three profiles to INDUSTRIALS_CAPITAL_GOODS in validation-pending state.

Deterministic scoring:
- ten dimensions totaling 100;
- mandatory evidence/history gates;
- no missing-input renormalization;
- distinct growth and cash-flow contracts for EPC, capital equipment and defence;
- symbol-independent methodology;
- unknown Industry → METHOD_NOT_AVAILABLE.

Incremental isolation/regression:
- PHARMA_V1 isolated;
- BANK_NBFC isolated;
- completed IT_TECH preserved;
- TORNTPHARM golden 75.1575 preserved;
- AUROPHARMA fail-closed golden preserved;
- universal Research workspace preserved.

Normal runtime scoring remains blocked while lifecycle = K4_FROZEN_PENDING. Promotion occurs only after owner-local Checkpoint B validation passes.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 2 · Checkpoint B validation correction — 22 September 2026

Owner-local Checkpoint B validation initially reported 2 failed tests and 49 passed.

Both failures were stale expectations created by legitimate prior state transitions:

1. `industrialsK4aMethodologyContract.test.ts` still expected `CHECKPOINT_A_OWNER_APPROVAL_REQUIRED` after Checkpoint A had already been owner-approved and frozen to `CHECKPOINT_A_OWNER_APPROVED_LOCKED`.
2. `scoringProfileResolution.test.ts` still expected completed `IT_TECH` to fail closed to GENERAL. IT_TECH is now an implemented engine identity, so profile resolution correctly returns `IT_TECH` with `SECTOR_RULE`; its legacy ruleProfile remains GENERAL because specialised IT scoring is separately owned by the read-only K4B authority rather than the old GENERAL-derived database scaffold.

Only the tests were corrected. No runtime methodology, classification, score, recommendation, persistence, provider, scheduler, deployment or production behavior was changed.

Checkpoint B remains LOCAL VALIDATION PENDING until the corrected suite is rerun.


---

## K4 Package 2 · INDUSTRIALS_CAPITAL_GOODS FINAL CLOSURE — 22 September 2026

Owner-local corrected Checkpoint B suite and TypeScript passed completely.

Final state:
- Checkpoint A = COMPLETE / PASS / FROZEN;
- Checkpoint B = COMPLETE / PASS / CLOSED;
- registry lifecycle = IMPLEMENTED;
- supported subprofiles = PROJECT_EPC / CAPITAL_EQUIPMENT_ELECTRICAL / DEFENCE_AEROSPACE;
- ticker-specific methodology routing = NO;
- missing mandatory evidence = fail closed;
- working-capital/cash-conversion evidence remains mandatory;
- PHARMA_V1 / BANK_NBFC / IT_TECH isolation = PASS;
- golden controls = PASS;
- universal Research shell = PASS;
- score persistence = OFF;
- recommendation persistence = OFF.

**K4 Package 2 · INDUSTRIALS_CAPITAL_GOODS = COMPLETE / PASS / CLOSED.**

K4 Package 3 — AUTO_COMPONENTS Checkpoint A is now IN PROGRESS.


---

## K4 Package 3 · AUTO_COMPONENTS · Checkpoint A implementation — 22 September 2026

INDUSTRIALS_CAPITAL_GOODS is closed COMPLETE / PASS.

Added:
- `autoComponentsK4aMethodologyContract.ts`;
- `autoComponentsK4aMethodologyContract.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_3_AUTO_COMPONENTS_CHECKPOINT_A.md`.

Proposed subprofiles:
1. AUTO_OEM — M&M and TVSMOTOR references;
2. AUTO_COMPONENTS — MOTHERSON and SONACOMS references.

Key methodology locks proposed:
- Industry selects methodology; Sector alone cannot;
- OEM and component economics remain separate;
- EV transition is exposure/risk/durability metadata, not an automatic third score;
- minimum 3 annual years / 8 quarters / 252 trading days;
- cash conversion and ROCE/ROIC are mandatory;
- capex-cycle context is mandatory;
- no cross-subprofile peer percentiles;
- unknown Industry → METHOD_NOT_AVAILABLE;
- numeric recommendation thresholds remain subprofile-owned and unset.

Runtime activation remains OFF pending owner-local Checkpoint A validation and approval.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 3 · AUTO_COMPONENTS · Checkpoint A validation correction — 22 September 2026

Owner-local Checkpoint A validation initially reported 2 failed tests and 24 passed.

Both failures were stale registry expectations after the legitimate closure of earlier K4 packages:

1. the registry test still expected 9 packages in `K4_FROZEN_PENDING`; after IT_TECH and INDUSTRIALS_CAPITAL_GOODS are implemented, the correct count is 8;
2. the registry test still expected `PROJECT_EPC` to belong to a pending Industrials engine; INDUSTRIALS_CAPITAL_GOODS is now implemented, so the correct lifecycle is `IMPLEMENTED`.

Only regression expectations were updated. No AUTO methodology, routing, scoring, recommendation, production, persistence, provider, scheduler or deployment behavior changed.

AUTO_COMPONENTS Checkpoint A remains LOCAL VALIDATION PENDING until the corrected suite is rerun.


---

## K4 Package 3 · AUTO_COMPONENTS · Checkpoint A FINAL — 22 September 2026

Owner-local contract tests and TypeScript passed completely and the owner approved proceeding.

`AUTO_COMPONENTS_K4A_METHODOLOGY_V1` is now frozen with two subprofiles:
- AUTO_OEM;
- AUTO_COMPONENTS.

EV transition remains exposure/risk/durability metadata rather than a separate score.

Runtime activation remains OFF until Checkpoint B portability/isolation validation passes.

**AUTO_COMPONENTS Checkpoint A = COMPLETE / PASS / FROZEN.**

Checkpoint B is now IN PROGRESS.


---

## K4 Package 3 · AUTO_COMPONENTS · Checkpoint B implementation — 22 September 2026

Checkpoint A is frozen COMPLETE / PASS.

Implemented:
- `autoComponentsK4bScoringMethodology.ts`;
- `autoComponentsK4bScoringMethodology.test.ts`;
- `autoComponentsK4bIsolationRegression.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_3_AUTO_COMPONENTS_CHECKPOINT_B.md`;
- canonical router extended for AUTO_OEM / AUTO_COMPONENTS coverage including tractors/farm equipment and tyres/rubber products;
- registry maps both profiles to AUTO_COMPONENTS in validation-pending state.

Deterministic scoring:
- ten dimensions totaling 100;
- mandatory evidence/history gates;
- no missing-input renormalization;
- distinct OEM vs component growth contracts;
- EV transition remains durability/risk metadata and never creates a second score;
- symbol-independent methodology;
- unknown Industry → METHOD_NOT_AVAILABLE.

Incremental isolation/regression:
- PHARMA_V1 isolated;
- BANK_NBFC isolated;
- completed IT_TECH preserved;
- completed INDUSTRIALS_CAPITAL_GOODS preserved;
- TORNTPHARM golden 75.1575 preserved;
- AUROPHARMA fail-closed golden preserved;
- universal Research workspace preserved.

Normal runtime scoring remains blocked while lifecycle = K4_FROZEN_PENDING. Promotion occurs only after owner-local Checkpoint B validation passes.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 3 · AUTO_COMPONENTS · Checkpoint B validation correction — 22 September 2026

Owner-local Checkpoint B validation initially reported 1 failed test and 50 passed.

The single failure was a stale Checkpoint A expectation:
- `autoComponentsK4aMethodologyContract.test.ts` still expected `CHECKPOINT_A_OWNER_APPROVAL_REQUIRED`;
- the contract had already been owner-approved and frozen to `CHECKPOINT_A_OWNER_APPROVED_LOCKED`.

Only the regression expectation was updated. No AUTO routing, scoring methodology, recommendation behavior, persistence, provider, production, scheduler or deployment behavior changed.

AUTO_COMPONENTS Checkpoint B remains LOCAL VALIDATION PENDING until the corrected suite is rerun.


---

## K4 Package 3 · AUTO_COMPONENTS FINAL CLOSURE — 22 September 2026

Owner-local corrected Checkpoint B suite and TypeScript passed completely.

Final state:
- Checkpoint A = COMPLETE / PASS / FROZEN;
- Checkpoint B = COMPLETE / PASS / CLOSED;
- registry lifecycle = IMPLEMENTED;
- supported subprofiles = AUTO_OEM / AUTO_COMPONENTS;
- ticker-specific methodology routing = NO;
- missing mandatory evidence = fail closed;
- EV transition = durability/risk/exposure metadata only;
- PHARMA_V1 / BANK_NBFC / IT_TECH / INDUSTRIALS_CAPITAL_GOODS isolation = PASS;
- golden controls = PASS;
- universal Research shell = PASS;
- score persistence = OFF;
- recommendation persistence = OFF.

**K4 Package 3 · AUTO_COMPONENTS = COMPLETE / PASS / CLOSED.**

K4 Package 4 — CHEMICALS_V1 Checkpoint A is now IN PROGRESS.


---

## K4 Package 4 · CHEMICALS_V1 · Checkpoint A implementation — 22 September 2026

AUTO_COMPONENTS is closed COMPLETE / PASS.

Added:
- `chemicalsK4aMethodologyContract.ts`;
- `chemicalsK4aMethodologyContract.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_4_CHEMICALS_CHECKPOINT_A.md`.

Proposed subprofiles:
1. SPECIALTY_CHEMICALS — PIIND / SRF references; VINATIORGA control;
2. AGRO_FERTILISER — PIIND / DEEPAKFERT references;
3. COMMODITY_PROCESS_CHEMICALS — SRF / DEEPAKFERT references.

Key methodology locks proposed:
- Industry selects methodology; Sector alone cannot;
- minimum 3 annual years / 8 quarters / 252 trading days;
- cycle-normalised growth, margin and ROCE interpretation;
- capacity/utilisation must be reconciled with return on capital;
- feedstock/global pricing context mandatory where material;
- no cross-subprofile peer percentiles;
- unknown Industry → METHOD_NOT_AVAILABLE;
- numeric recommendation thresholds remain subprofile-owned and unset.

Runtime activation remains OFF pending owner-local Checkpoint A validation and approval.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 4 · CHEMICALS_V1 · Checkpoint A validation correction — 22 September 2026

Owner-local Checkpoint A validation initially reported 2 failed tests and 24 passed.

Both failures were stale registry lifecycle expectations after AUTO_COMPONENTS was legitimately promoted to IMPLEMENTED:
1. pending K4 package count was still hard-coded as 8, but the correct current count is 7;
2. AUTO_OEM was still expected to belong to a pending AUTO_COMPONENTS engine, while AUTO_COMPONENTS is now IMPLEMENTED.

To prevent the same avoidable failure after every subsequent K4 package, the registry lifecycle test was improved rather than merely changing 8 → 7:
- total registry entries must remain 12;
- excluding inherited PHARMA_V1 and BANK_NBFC, exactly 10 K4 packages must exist;
- each K4 package must be either IMPLEMENTED or K4_FROZEN_PENDING.

AUTO_OEM lifecycle expectation was updated to IMPLEMENTED.

No Chemicals methodology, routing, scoring, recommendation, persistence, provider, production, scheduler or deployment behavior changed.

CHEMICALS_V1 Checkpoint A remains LOCAL VALIDATION PENDING until the corrected suite is rerun.


---

## K4 Package 4 · CHEMICALS_V1 · Checkpoint A FINAL — 22 September 2026

Owner-local contract tests and TypeScript passed completely and the owner approved proceeding.

`CHEMICALS_V1_K4A_METHODOLOGY_V1` is now frozen with three subprofiles:
- SPECIALTY_CHEMICALS;
- AGRO_FERTILISER;
- COMMODITY_PROCESS_CHEMICALS.

Runtime activation remains OFF until Checkpoint B portability/isolation validation passes.

**CHEMICALS_V1 Checkpoint A = COMPLETE / PASS / FROZEN.**

Checkpoint B is now IN PROGRESS.


---

## K4 Package 4 · CHEMICALS_V1 · Checkpoint B implementation — 22 September 2026

Checkpoint A is frozen COMPLETE / PASS.

Implemented:
- `chemicalsK4bScoringMethodology.ts`;
- `chemicalsK4bScoringMethodology.test.ts`;
- `chemicalsK4bIsolationRegression.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_4_CHEMICALS_CHECKPOINT_B.md`;
- canonical router extended for SPECIALTY_CHEMICALS / AGRO_FERTILISER / COMMODITY_PROCESS_CHEMICALS;
- registry maps all three profiles to CHEMICALS_V1 in validation-pending state.

Deterministic scoring:
- ten dimensions totaling 100;
- mandatory evidence/history gates;
- no missing-input renormalization;
- distinct growth contracts for specialty, agro/fertiliser and commodity/process chemicals;
- cycle normalization required;
- symbol-independent methodology;
- unknown Industry → METHOD_NOT_AVAILABLE.

Incremental isolation/regression:
- PHARMA_V1 isolated;
- BANK_NBFC isolated;
- completed IT_TECH preserved;
- completed INDUSTRIALS_CAPITAL_GOODS preserved;
- completed AUTO_COMPONENTS preserved;
- TORNTPHARM golden 75.1575 preserved;
- AUROPHARMA fail-closed golden preserved;
- universal Research workspace preserved.

Normal runtime scoring remains blocked while lifecycle = K4_FROZEN_PENDING. Promotion occurs only after owner-local Checkpoint B validation passes.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 4 · CHEMICALS_V1 · Checkpoint B validation correction — 22 September 2026

Owner-local Checkpoint B validation initially reported 1 failed test and 51 passed.

The single failure was a stale Checkpoint A expectation:
- `chemicalsK4aMethodologyContract.test.ts` still expected `CHECKPOINT_A_OWNER_APPROVAL_REQUIRED`;
- the contract had already been owner-approved and frozen to `CHECKPOINT_A_OWNER_APPROVED_LOCKED`.

Only the regression expectation was updated. No Chemicals routing, scoring methodology, recommendation behavior, persistence, provider, production, scheduler or deployment behavior changed.

CHEMICALS_V1 Checkpoint B remains LOCAL VALIDATION PENDING until the corrected suite is rerun.


---

## K4 Package 4 · CHEMICALS_V1 FINAL CLOSURE — 22 September 2026

Owner-local corrected Checkpoint B suite and TypeScript passed completely.

Final state:
- Checkpoint A = COMPLETE / PASS / FROZEN;
- Checkpoint B = COMPLETE / PASS / CLOSED;
- registry lifecycle = IMPLEMENTED;
- supported subprofiles = SPECIALTY_CHEMICALS / AGRO_FERTILISER / COMMODITY_PROCESS_CHEMICALS;
- ticker-specific methodology routing = NO;
- missing mandatory evidence = fail closed;
- cycle normalization = mandatory;
- PHARMA_V1 / BANK_NBFC / prior K4 engine isolation = PASS;
- golden controls = PASS;
- universal Research shell = PASS;
- score persistence = OFF;
- recommendation persistence = OFF.

**K4 Package 4 · CHEMICALS_V1 = COMPLETE / PASS / CLOSED.**

K4 Package 5 — HEALTHCARE_SERVICES_V1 Checkpoint A is now IN PROGRESS.


---

## K4 Package 5 · HEALTHCARE_SERVICES_V1 · Checkpoint A implementation — 22 September 2026

CHEMICALS_V1 is closed COMPLETE / PASS.

Added:
- `healthcareServicesK4aMethodologyContract.ts`;
- `healthcareServicesK4aMethodologyContract.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_5_HEALTHCARE_SERVICES_CHECKPOINT_A.md`.

Initial scope intentionally contains one subprofile:
- HOSPITAL_OPERATORS — MAXHEALTH / NH / MEDANTA / YATHARTH references.

Key methodology locks proposed:
- Industry selects methodology; Sector alone cannot;
- diagnostics are explicitly excluded from hospital scoring and must fail review pending separate methodology authority;
- minimum 3 annual years / 8 quarterly observations / 252 trading days;
- hospital operating evidence includes occupancy, ARPOB/equivalent and bed-ramp context where disclosed;
- bed additions must reconcile with ramp and ROCE;
- cash conversion must reconcile with capex/receivables;
- unknown/non-hospital Healthcare identity → METHOD_NOT_AVAILABLE / review;
- numeric recommendation thresholds remain subprofile-owned and unset.

Runtime activation remains OFF pending owner-local Checkpoint A validation and approval.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 5 · HEALTHCARE_SERVICES_V1 · Checkpoint A validation correction — 22 September 2026

Owner-local Checkpoint A validation initially reported 1 failed test and 26 passed.

The single failure was a stale registry lifecycle expectation:
- `SPECIALTY_CHEMICALS` was still expected to belong to CHEMICALS_V1 with lifecycle `K4_FROZEN_PENDING`;
- CHEMICALS_V1 had already been closed and promoted to `IMPLEMENTED`.

Only the regression expectation was updated. No Healthcare Services methodology, routing, scoring, recommendation, persistence, provider, production, scheduler or deployment behavior changed.

HEALTHCARE_SERVICES_V1 Checkpoint A remains LOCAL VALIDATION PENDING until the corrected suite is rerun.


---

## K4 Package 5 · HEALTHCARE_SERVICES_V1 · Checkpoint A FINAL — 22 September 2026

Owner-local tests and TypeScript passed. The hospital-only initial methodology is frozen.

From this checkpoint onward, K4 regression tests must avoid stale lifecycle assumptions:
- completed engines are asserted as IMPLEMENTED;
- only the active package may be K4_FROZEN_PENDING;
- package-count invariants remain dynamic;
- no test may retain a pre-approval or pre-closure expected state after the state transition is committed.

**HEALTHCARE_SERVICES_V1 Checkpoint A = COMPLETE / PASS / FROZEN.**


---

## K4 Package 5 · HEALTHCARE_SERVICES_V1 · Checkpoint B implementation — 22 September 2026

Checkpoint A is frozen COMPLETE / PASS.

Implemented:
- `healthcareServicesK4bScoringMethodology.ts`;
- `healthcareServicesK4bScoringMethodology.test.ts`;
- `healthcareServicesK4bIsolationRegression.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_5_HEALTHCARE_SERVICES_CHECKPOINT_B.md`;
- registry maps `HOSPITAL` to HEALTHCARE_SERVICES_V1 in validation-pending state;
- diagnostics remain deliberately unmapped from the hospital engine.

Deterministic scoring:
- ten dimensions totaling 100;
- hospital-specific operating durability evidence;
- no missing-input renormalization;
- diagnostics → REVIEW_REQUIRED / separate methodology required;
- symbol-independent methodology;
- score/recommendation persistence remain OFF.

Regression policy improvement:
- the current package test is lifecycle-stable and valid both before and after promotion;
- no stale pre-approval/pre-closure expectation is intentionally carried into this B suite;
- completed packages are asserted only in their durable IMPLEMENTED state.

Incremental isolation/regression:
- PHARMA_V1 isolated;
- BANK_NBFC isolated;
- IT_TECH / INDUSTRIALS_CAPITAL_GOODS / AUTO_COMPONENTS / CHEMICALS_V1 preserved;
- TORNTPHARM golden 75.1575 preserved;
- AUROPHARMA fail-closed golden preserved;
- universal Research workspace preserved.

Normal runtime scoring remains blocked while lifecycle = K4_FROZEN_PENDING. Promotion occurs only after owner-local Checkpoint B validation passes.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.


---

## K4 Package 5 · HEALTHCARE_SERVICES_V1 · Checkpoint B precision correction — 22 September 2026

Owner-local Checkpoint B validation initially reported 1 failed test and 52 passed.

The failure was not a stale lifecycle expectation and not a methodology error. JavaScript floating-point arithmetic produced `73.99999999999999` for a weighted score that is mathematically 74.

Correction:
- deterministic K4B scorers now apply a stable output rounding step with `Number(value.toFixed(6))` to the final weighted overall score;
- the same stable precision rule was applied proactively to IT_TECH, INDUSTRIALS_CAPITAL_GOODS, AUTO_COMPONENTS and CHEMICALS_V1 scorers to prevent the same numerical artifact from recurring.

No weights, dimensions, methodology, evidence rules, routing, recommendation logic, persistence, provider behavior, production behavior, scheduler or deployment behavior changed.

HEALTHCARE_SERVICES_V1 Checkpoint B remains LOCAL VALIDATION PENDING until the corrected suite is rerun.


---

## K4 Package 5 · HEALTHCARE_SERVICES_V1 FINAL CLOSURE — 22 September 2026

Owner-local corrected Checkpoint B suite and TypeScript passed completely.

Final state:
- Checkpoint A = COMPLETE / PASS / FROZEN;
- Checkpoint B = COMPLETE / PASS / CLOSED;
- registry lifecycle = IMPLEMENTED;
- supported authority = HOSPITAL;
- diagnostics remain deliberately outside hospital scoring;
- ticker-specific methodology routing = NO;
- missing mandatory evidence = fail closed;
- PHARMA_V1 / BANK_NBFC / prior K4 engine isolation = PASS;
- golden controls = PASS;
- universal Research shell = PASS;
- stable weighted-score precision = 6 decimals;
- score persistence = OFF;
- recommendation persistence = OFF.

**K4 Package 5 · HEALTHCARE_SERVICES_V1 = COMPLETE / PASS / CLOSED.**

K4 Package 6 — FIN_SERVICES_NON_LENDER Checkpoint A is now IN PROGRESS.


---

## K4 Package 6 · FIN_SERVICES_NON_LENDER · Checkpoint A implementation — 22 September 2026

HEALTHCARE_SERVICES_V1 is closed COMPLETE / PASS.

Added:
- `finServicesNonLenderK4aMethodologyContract.ts`;
- `finServicesNonLenderK4aMethodologyContract.test.ts`;
- `docs/PortfolioAI_GATE_K_K4_6_FIN_SERVICES_NON_LENDER_CHECKPOINT_A.md`.

Proposed mandatory subprofiles:
1. CAPITAL_MARKETS_AMC — NAM-INDIA / HDFCAMC / ANGELONE / CAMS;
2. INSURANCE — STARHEALTH;
3. FINTECH_PLATFORM — PAYTM / POLICYBZR.

Key methodology locks proposed:
- non-lender Financial Services must not inherit BANK_NBFC lender metrics or thresholds;
- no NPA / CET1 / deposit-growth methodology leakage;
- Nifty Bank is not a benchmark authority for this package;
- subprofile-specific evidence and valuation are mandatory;
- insurance claims/reserving evidence cannot be replaced by generic margins;
- fintech growth cannot override cash burn/unit economics;
- cross-subprofile peer percentiles prohibited;
- unknown Industry → METHOD_NOT_AVAILABLE;
- numeric recommendation thresholds remain subprofile-owned and unset.

No-stale regression policy remains active for this package and subsequent K4 packages.

Runtime activation remains OFF pending owner-local Checkpoint A validation and approval.

No provider calls, production mutation/migration, score/recommendation persistence, scheduler change, deployment, PR merge or trading action occurred.
